CAN - Vitrivax - Series B a Series of CGF2021 LLC
Claymont, De
CAN - Vitrivax - Series B a Series of CGF2021 LLC is a venture capital fund managed by Can - Vitrivax -. Its SEC Form D filing reports $216,500 raised, a $216,500 target, 15 investors, and a first sale on September 29, 2025.
Amount Raised
$216,500
Target Size
$216,500
Investors
15
Date Filed
2025-10-09
Dry powder breakdown
Est. Remaining
$162,375
Deployed
$54,125
25% deployed36 months remaining (4yr model)
Raised 100% of $216,500 target
Filing details
Fund vehicleCAN - Vitrivax - Series B a Series of CGF2021 LLC
FirmCan - Vitrivax -
IndustryVenture Capital Fund
Address2093 PHILADELPHIA PIKE, CLAYMONT, DE
Phone(360) 946-0604
Accession #0002090207-25-000001
Related personsView on SEC EDGAR ↗